Mindpeak announces scanner agnostic CE-marked PD-L1 AI solution to support Lung Cancer Diagnosis
We at Mindpeak GmbH are very happy to announce the CE mark for our „Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI“, a plug-and-play AI solution to detect and quantify PD-L1 expression within user-defined Regions of Interest (RoI) on non-small-cell lung cancer. In a study our software showed a 96.5% agreement for the most relevant scanners on the market. Mindpeak Lung PD-L1, our 7th CE marked product, is a milestone in supporting pathologists in the diagnosis of Lung Cancer, which is among the most difficult tasks for pathologists. It identifies tumorous cells and quantifies them to support TPS-scoring.
You may also be interested in
Find out more about our AI-based diagnostics
